ALTME fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
TME Pharma NV is a clinical-stage biopharmaceutical company, which focuses on therapeutics targeting the tumor microenvironment or TME. The firm is active in pioneering the development of a new class of proprietary therapeutics called Spiegelmers. Its pipeline includes NOX-A12 and NOX-E36. The company was founded on January 16, 2015 and is headquartered in Berlin, Germany.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
ALTME does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future
Financial health
Financial position and solvency of the company